Article Per Year (5 Year)
p-Index From 2020 - 2025
0.23
P-Index
This Author published in this journals
All Journal Medula
Aqil, Faiq Akhmad
Unknown Affiliation
Education Medicine & Pharmacology Neuroscience Public Health

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
a Comparison Between Dexamethasone and Prednisolone in ARDS Patients: Literature Review Aqil, Faiq Akhmad; Oktarlina, Rasmi Zakiah; Junando, Mirza; Pardilawati, Citra Yuliyanda
Medula Vol 14 No 8 (2024): Medula
Publisher : CV. Jasa Sukses Abadi

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.53089/medula.v14i8.1275

Abstract

During the COVID-19 pandemic, dexamethasone and methylprednisolone are used to treat COVID-19 patients, particularly those who have acute respiratory distress syndrome (ARDS). Numerous studies have demonstrated that dexamethasone significantly improves respiratory function and lowers mortality in COVID-19 patients, particularly those who need mechanical ventilation. Patients with ARDS with COVID-19 who received dexamethasone had fewer days alive and ventilator-free days, according to a randomized study like the CoDEX trial. But methylprednisolone has also demonstrated encouraging outcomes in treating severe COVID-19 pneumonia, particularly when used as a short-term treatment. The dosage and mode of administration of the two medications differ; dexamethasone is more frequently used to treat the systemic inflammation brought on by this viral infection.
Co-Authors Junando, Mirza Pardilawati, Citra Yuliyanda Rasmi Zakiah Oktarlina